Measuring innovation and value in healthcare systems

Could personalised medicine increase inequality to medicine access?

The economics of personalised medicine in low and middle income countries

Creating a culture of shared data

Accelerating research to the bedside

The Innovative Medicines Initiative

Lenalidomide with rituximab for mantle cell lymphoma

Why we are not ready for personalised medicine

Genetically profiling entire populations, starting with Estonia

How does ancestry affect your health?

Personalised medicine differs from precision medicine

Approaches to screening and early detection across Europe